Skip to main
VIRX
VIRX logo

Viracta Therapeutics (VIRX)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Viracta Therapeutics (VIRX) Stock

About Viracta Therapeutics (VIRX)

Viracta Therapeutics, Inc. a clinical-stage, biomarker-directed precision oncology company focused on new medicines for the treatment of virus-associated malignancies. It develops antiviral agent valganciclovir as an oral combination therapy which is in a Phase 2 clinical trial for EBV-positive lymphomas. The company was founded on February 10, 1998 and is headquartered in Cardiff, CA.
Market cap$685.6K
Today's volume30.06K
Revenue (TTM)
Avg. daily volume110.44K
EBITDA (TTM)-$46.07M
Open$0.02
Price / earnings ratio-0.02x
Today's range$0.02 - $0.02
Debt / equity
52 week range$0.01 - $0.65
5 year debt / equity
Beta (LTM)0.56x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio0.76x
Ex-dividend date
Next earningsMay 2, 2025
Dividend payable date

Viracta Therapeutics Stock Rating

What analysts recommend for VIRX stock, on a scale from 1(buy) to 5(sell).
Buy
Strong Buy 22%
Buy 56%
Hold 22%
Sell 0%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Jun 17, 2025, the market cap for VIRX stock is $685.6K

The current P/E ratio for VIRX stock is -0.02

The 52-week high for VIRX stock is $0.65. The current VIRX stock price $undefined is 100.00% below its 52-week high

The 52-week low for VIRX stock is $0.01. The current VIRX stock price $undefined has increased 100.00% from its 52-week low

No, the VIRX stock does not pay dividends to its shareholders

The target price for VIRX stock is $10.92 based on the average of what a group of analyst think VIRX stock could be worth at a future date. This is not a prediction by Public.com

How to buy VIRX stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in VIRX stock

    Navigate to the Explore page. Then, type VIRX into the search bar. When you see VIRX stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased VIRX stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Viracta Therapeutics Stock Earnings

The value each VIRX share was expected to gain vs. the value that each VIRX share actually gained.

Viracta Therapeutics (VIRX) reported Q3 2024 earnings per share (EPS) of -$0.27, missing estimates of -$0.24 by 12.50%. In the same quarter last year, Viracta Therapeutics's earnings per share (EPS) was -$0.33. Viracta Therapeutics is expected to release next earnings on 05/02/2025, with an earnings per share (EPS) estimate of -$0.19.

Buy Viracta Therapeutics (VIRX) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.